Study provides insights into how the immune system of kidney transplant recipients responds to COVID-19
Researchers visualize α-synuclein pathology in living patients with a neurodegenerative disorder
30 August 2022End sexist scheduling of major sporting events to boost gender equality, urge experts
30 August 2022Study provides insights into how the immune system of kidney transplant recipients responds to COVID-19
Kidney transplant recipients (KTRs) have experienced severe symptoms and poor outcomes with COVID-19. Because the long-term antirejection immunosuppressive drugs that KTRs take could inhibit the development of protective anti-COVID-19 immunity, most hospitals have reduced the drugs’ doses in KTRs with COVID-19. Surprisingly, reported rates of acute rejection have been low despite reduced immunosuppression in these patients. A new study in JASN provides a potential explanation.
